Practice with national-level exam (FACT, FACT Plus, NET, CUET, etc.) mocks, learn from structured notes, and get your doubts solved in one place.
Lead and antimony in kohl and surma (the South Asian and Middle Eastern pediatric lead-poisoning route), mercury in skin-lightening creams (FDA imports alert IA-66-01), banned azo colourants (Sudan, Para Red, Rhodamine B) in lipstick, formaldehyde release from quaternium-15 and DMDM hydantoin in shampoos, and the US FDA / EU Regulation 1223/2009 / India Drugs and Cosmetics Act 1940 enforcement frame.
Last updated:
The chemistry of cosmetics enforcement occupies an unusual position in forensic chemistry casework: the products at issue are applied intentionally to the body, often daily, by people who have no reason to suspect they are introducing toxic heavy metals, carcinogenic colourants, or formaldehyde-releasing preservatives. The exposure is chronic rather than acute, the affected populations often include infants and children who are exposed through caregivers' use, and the regulatory frameworks in different jurisdictions reflect dramatically different risk tolerances.
Three groups of chemical hazards dominate the current casework landscape. Heavy metals, particularly lead, antimony, and mercury, enter cosmetics either as deliberate additives with a cultural or commercial function (galena-based kohl, mercury-based skin-lightening ammoniated mercury preparations, mercury iodide in certain fairness creams) or as contaminants in inorganic pigments. The toxicological concern for lead and mercury is the absence of any established safe blood concentration, particularly in children.
Banned colourants, including azo dyes (Sudan I-IV, Para Red, Orange II) and triarylmethane dyes (Rhodamine B, Crystal Violet), appear in lipstick and blush products marketed primarily in South Asian and African markets where regulatory enforcement is weaker, providing intense coloration at low cost relative to permitted alternatives.
Formaldehyde and formaldehyde-releasing preservatives (FRPs) are a distinct category: formaldehyde is an effective antimicrobial and is permitted at regulated concentrations in cosmetics under most frameworks, but the liberation of free formaldehyde from FRP-preserved products during storage, and the consequent allergic contact dermatitis and, at high exposure, genotoxic risk, are an active area of regulatory review. The EU has progressively tightened the permitted FRP list and maximum free-formaldehyde concentrations; the US FDA is moving toward mandatory labelling of formaldehyde release from cosmetics under the Modernization of Cosmetics Regulation Act 2022 (MoCRA).
This topic covers the chemistry, the toxicology, and the multi-jurisdictional analytical and regulatory framework for each category.
A product used for thousands of years as an eye cosmetic across South Asia and the Middle East, applied to infants as a cultural practice, contains lead sulfide at concentrations that would trigger hazardous-materials handling requirements under occupational health law.
Test yourself on Forensic Chemistry with free, timed mocks.
Practice Forensic Chemistry questionsKohl (also romanised as kuhl, surma, kajal, or al-kohl depending on region) is a dark-coloured powder applied to the eyes and eyelids as a cosmetic and cultural practice spanning ancient Egypt, the South Asian subcontinent, and the broader Islamic world. The traditional mineral form of kohl is galena (lead(II) sulfide, PbS), a naturally occurring mineral with a grey-black metallic lustre. Ground galena has been used since at least 3100 BCE, documented in ancient Egyptian cosmetic containers examined by the Louvre. Traditional South Asian surma and kajal preparations often use galena as the primary pigment, though carbon-black (lampblack or kohl made from lamp soot) preparations also exist and do not carry the same lead burden.
The lead content of traditional kohl preparations can be extraordinary by any modern regulatory standard. Studies published in the journals Pediatrics and the Journal of Exposure Science and Environmental Epidemiology document lead concentrations of 40 to 80 per cent by mass in galena-based kohl samples obtained from South Asian and Middle Eastern market sources. A single application of a galena-based kohl to an infant's eyes can deposit 0.2 to 2 mg of lead on the eyelid surface and conjunctiva. Dermal absorption of lead from cosmetics is lower than gastrointestinal absorption, but infants routinely transfer eyelid kohl to their fingers and mouths; the hand-to-mouth pathway for lead is the primary absorption route, with gastrointestinal absorption of ionic lead in children estimated at 40 to 50 per cent (versus roughly 10 per cent in adults).
The antimony co-contamination is significant. Galena ore is geologically associated with antimony-bearing minerals (stibnite, Sb2S3). Commercial kohl preparations made from natural galena deposits, rather than synthetic PbS, consistently contain antimony at 2 to 10 per cent by mass. Antimony, particularly in the trivalent form (Sb(III)), is a probable human carcinogen (IARC Group 2A for antimony trioxide), a respiratory irritant, and a cardiac arrhythmia risk at systemic levels. Blood-antimony elevation has been documented in children using kohl in studies from Saudi Arabia (Al-Saleh et al., 2001, Science of the Total Environment) and the United Arab Emirates.
The US FDA Import Alert IA-66-01 covers kohl, kajal, and surma containing lead and has been in place since 1996. Under 21 CFR 73.3045, only lead acetate (at concentrations sufficient to darken graying hair in hair colour preparations) is permitted as a lead compound in US cosmetics, and even that exemption is under review. All other lead-containing cosmetics, including galena-based kohl, are adulterated under FD&C Act Section 601(a) (cosmetics injurious to health). The Import Alert places these products on DWPE (Detention Without Physical Examination).
The EU Regulation 1223/2009 (the Cosmetics Regulation) Annex II lists lead and its compounds as prohibited substances in cosmetics products (Entry 209). The EU Scientific Committee on Consumer Safety (SCCS) has opined that there is no safe level for lead in cosmetics. EU Regulation 1223/2009 Annex II, Entry 35, similarly prohibits antimony and its compounds (with the exception of antimony trioxide used as a flame retardant in textile fibres, which has no cosmetics application relevance). Products imported into the EU in violation of these entries are notified through the RAPEX system (Rapid Alert System for dangerous non-food products, operated in parallel with RASFF for food).
In India, the Drugs and Cosmetics Act 1940 (D&C Act) and the Cosmetics Rules 2020 (which replaced Schedule S to the Drugs and Cosmetics Rules 1945) regulate the composition of cosmetics. Schedule 1 of the Cosmetics Rules 2020 prohibits mercury (above trace in preservative applications), lead, and a range of other heavy metals as cosmetic ingredients. However, traditional preparations such as surma and kajal are often sold through informal markets and are not systematically captured by the CDSCO (Central Drugs Standard Control Organisation) inspection and sampling programme, which focuses on licensed cosmetic manufacturers. The CDSCO has issued advisory notices on kohl lead content but does not have a national surveillance programme equivalent in coverage to the US FDA's Import Alert or the EU RAPEX system.
A product marketed with the aspirational language of radiance and glow can contain mercury at concentrations that would require hazmat disposal under environmental regulation, and it crosses international borders in a suitcase with no declaration.
Skin-lightening cosmetics (marketed as fairness creams, brightening serums, or whitening treatments) are a major global market, estimated at USD 8.6 billion in 2020 and concentrated in South Asia, Sub-Saharan Africa, East Asia, and diasporic communities in North America and Europe. The legitimate active ingredients in permitted skin-lightening formulations include kojic acid, azelaic acid, niacinamide, and vitamin C (ascorbic acid) derivatives. However, a segment of the informal and grey-market product space has historically used inorganic mercury compounds, particularly ammoniated mercury (mercuric chloride-ammonia complex) and mercury iodide (HgI2), as the brightening agents. Mercury compounds inhibit melanogenesis by binding to the active-site cysteine of tyrosinase (the enzyme that catalyses the conversion of tyrosine to DOPA and dopaquinone in the melanin biosynthesis pathway), producing a rapid visible skin lightening.
The systemic toxicology of inorganic mercury exposure through skin is well characterised. Percutaneous absorption of ionic mercury from creams is substantially higher than for elemental mercury; skin absorption of Hg2+ from experimental cream application has been estimated at 1 to 12 per cent per application in human in vitro studies. Chronic systemic mercury exposure from skin-lightening cream use causes nephrotic syndrome (proteinuria, hypoalbuminaemia, oedema), peripheral neuropathy, tremor, and neuropsychiatric effects. Case series from the UK (Barber 1993, Lancet), the US (McFadden et al., 2019, Environmental Health), and the EU (SCCS Opinion SCCS/1566/15) document mercury poisoning from skin-lightening cream use in adult women. A notable cluster of nephrotic syndrome cases in Somali immigrant women in London in the 1990s was traced to a mercury-containing cream imported from East Africa.
The US FDA maximum permitted mercury concentration in cosmetics is 1 mg/kg (1 ppm) in rinse-off preparations and 65 mg/kg (65 ppm) in eye-area preparations as a preservative only (21 CFR 700.3, referencing the exemptions). The US FDA Import Alert IA-66-01 covers mercury-containing skin-lightening products, particularly those from India, Pakistan, China, and the Philippines. FDA analysis of skin-lightening products sampled from South Asian and Latino beauty supply stores in the US (described in FDA Import Alert documentation and in academic surveys such as Noonan et al., 2012) has found mercury at 6,000 to 33,000 ppm, three to four orders of magnitude above the US FDA limit.
The EU Regulation 1223/2009 Annex II, Entry 221, prohibits mercury and its compounds in cosmetics. The only exceptions are phenyl mercuric compounds permitted at up to 0.007 per cent (as Hg) in eye-area cosmetics and mascaras as preservatives, and thiomersal at the same concentration. All other mercury compounds, including ammoniated mercury and mercury iodide, are prohibited without exception. The SCCS Opinion on mercury (SCCS/1566/15, 2016) recommends that even the thiomersal exemption be removed given availability of safe alternatives.
The same Sudan dyes found in adulterated chilli powder appear in lipstick, blush, and eye shadow. Lipstick has a unique exposure characteristic: the average woman ingests an estimated 4 mg of lipstick per day.
Lipstick is a lipid-based product (typically a mixture of castor oil, beeswax, carnauba wax, and emollients) that carries colourants on the lip surface. Because lipstick is applied to the lips, a significant fraction is ingested orally with food and saliva, or directly licked; the 4 mg per day ingestion estimate, from a 2011 paper in Environmental Health Perspectives, is widely cited in the risk-assessment literature for lipstick contaminants. This oral ingestion route makes the toxicological assessment of lipstick colourants different from other cosmetic products applied to skin (where the relevant route is primarily dermal) or hair (where the relevant route is primarily dermal with secondary respiratory).
The EU Regulation 1223/2009 Annex IV lists permitted cosmetic colourants with their application scope (hair, non-eye-area skin, eye area, rinse-off). Azo colourants permitted in cosmetics include certain approved D&C Red numbers, DC Yellow 5, and others that have passed the SCCS risk assessment process. Sudan I-IV, Para Red, Rhodamine B, Orange II, and related compounds are not listed in Annex IV, meaning their presence in any cosmetic product constitutes an unauthorised colourant under Article 14 of Regulation 1223/2009, making the product non-compliant.
Rhodamine B (C28H31ClN2O3, MW 479.0, a xanthene dye with brilliant pink fluorescence) is particularly concerning in lip cosmetics because it is a suspected carcinogen with genotoxic potential; it appears on the EU REACH SVHC (Substances of Very High Concern) candidate list and is classified under GHS as a Category 2 carcinogen suspect (H351). Rhodamine B has been detected in lipstick samples from South Asian markets at concentrations of 0.1 to 1.2 mg/g in surveys published in the Journal of Analytical Toxicology and in CDSCO market surveillance reports. At 4 mg per day ingestion per day, a 0.5 mg/g (500 ppm) concentration yields 2 micrograms of Rhodamine B per day, a dose for which no established tolerable daily intake exists.
Sudan dyes in cosmetics arise by two routes. First, direct adulteration: the same low-cost Sudan I-IV powders used to adulterate chilli are used to provide red colouration in lipstick and blush. Second, indirect contamination: high-oleic vegetable oils such as palm oil or chilli-extract oleoresins used as colourant carriers in cosmetics were found to contain Sudan dyes that originated upstream in adulterated agricultural products.
Para Red (4-nitroaniline coupled to 2-naphthol, C16H11N3O3, MW 293.3) appears in EU RASFF notifications for cosmetics and in US FDA import-alert documentation. Its genotoxic potential stems from the nitro group (reducible to the primary aromatic amine 4-aminoaniline by gut azo reductase and by nitro reductases in both the intestine and the skin). Orange II (4-[(4-hydroxyphenyl)azo]benzenesulfonic acid, sodium salt, C12H9N2NaO4S, MW 328.3) is an azo dye with an OH-phenyl ring that confers some water solubility; it appears in Indian market lipstick surveys at concentrations of 0.1 to 0.8 mg/g.
The analytical method for banned colourants in cosmetics uses HPLC-DAD or LC-MS/MS. The EU SCCS technical reference document and the US FDA Cosmetics Handbook both specify reversed-phase LC with visible wavelength DAD (wavelengths 500-550 nm for red azo dyes; 540 nm for Rhodamine B; 350 nm for Sudan I; 400 nm for Sudan III). The sample preparation dissolves the lipstick matrix in acetonitrile or a mixture of methanol-water (70:30). For LC-MS/MS confirmation, the primary MRM transitions used are: Rhodamine B (m/z 443.2 to 399.2, loss of C2H4 in positive ESI), Sudan I (m/z 249.1 to 156.1), Para Red (m/z 294.1 to 248.1). The EU CEN method EN 16280:2012 and the US CTFA analytical method reference guide describe validated procedures.
Quaternium-15, DMDM hydantoin, and three other FRPs are in roughly 20 per cent of personal-care products sold globally, and in every one of those products, some amount of formaldehyde is being released into the product and onto the user's skin.
Formaldehyde (HCHO) is an effective broad-spectrum antimicrobial, used as a preservative in cosmetics at concentrations up to 0.2 per cent free formaldehyde under EU Regulation 1223/2009. However, formaldehyde is also a confirmed human carcinogen (IARC Group 1, based on sufficient evidence of nasopharyngeal carcinoma in occupationally exposed workers and a mechanistic role in leukaemia) and a common sensitiser causing allergic contact dermatitis at very low concentrations. Because of its irritancy at higher concentrations, most cosmetic formulators use formaldehyde-releasing preservatives (FRPs) rather than direct formaldehyde addition.
The five principal FRPs in commercial cosmetics are:
Quaternium-15 (N-(3-chloroallyl)hexaminium chloride) is the most potent formaldehyde releaser among cosmetic FRPs; it releases approximately 6,000 ppm free formaldehyde under standard conditions (pH 6-7, 37°C). It is listed in the EU Regulation 1223/2009 Annex V as a permitted preservative (Entry 33) with a maximum concentration of 0.2 per cent free formaldehyde in ready-to-use cosmetics, with mandatory label statement "contains formaldehyde" when free formaldehyde exceeds 0.05 per cent.
DMDM hydantoin (1,3-bis(hydroxymethyl)-5,5-dimethylhydantoin) releases formaldehyde by hydrolysis of the N-CH2OH bonds. Its release rate is slower than quaternium-15 and pH-dependent; it is classified in Annex V, Entry 43, with the same 0.2 per cent free-formaldehyde limit.
Imidazolidinyl urea (Germall) and diazolidinyl urea (Germall Plus) are polycyclic FRPs that release formaldehyde slowly, making them popular in "mild" formulations; both are listed in Annex V (Entries 27 and 56 respectively). Bronopol (2-bromo-2-nitropropane-1,3-diol) releases both formaldehyde and nitrosating agents (which can react with secondary amines in the formulation to generate N-nitroso compounds, a separate carcinogenicity concern); it is permitted in the EU at 0.1 per cent (Annex V, Entry 7).
In the United States, FRPs are regulated under the FD&C Act cosmetic-adulteration provisions. There is no specific federal maximum concentration for formaldehyde in cosmetics; the FDA has relied on voluntary compliance and labelling under 21 CFR 701.3. The Modernization of Cosmetics Regulation Act 2022 (MoCRA), signed into law in December 2022, requires FDA to establish regulations for FRP labelling and to perform risk assessments on formaldehyde and formaldehyde-releasing ingredients, representing the first substantive reform of US cosmetic regulation since 1938.
In India, the Cosmetics Rules 2020 (under the Drugs and Cosmetics Act 1940) Schedule 3 (restricted cosmetic substances) limits total formaldehyde in shampoos and hair care products to 0.2 per cent, consistent with the EU limit. CDSCO guidance on FRPs references the EU Annex V entries as the Indian regulatory baseline.
| FRP or heavy metal | Mechanism / route | India limit (Cosmetics Rules 2020) | US FDA limit / status | EU limit (Reg. 1223/2009) | Key lab detection method |
|---|---|---|---|---|---|
| Formaldehyde (free) | Direct antimicrobial; released from FRPs | 0.2% in ready-to-use (Schedule 3) | No specific federal limit; MoCRA 2022 review in progress | 0.2% (Annex V, mandatory label if >0.05%) | Nash reagent spectrophotometry; HPLC-UV; GC-MS headspace |
| Quaternium-15 | FRP: N-chloroallyl hexaminium releases ~6000 ppm HCHO | Same as free formaldehyde limit | FD&C Act voluntary; MoCRA 2022 review | Annex V Entry 33, max 0.2% as free HCHO | HPLC-DAD; LC-MS/MS; Nash colorimetric for HCHO |
ICP-MS for metals, HPLC-DAD for colourants, GC-MS headspace for formaldehyde: three instrument platforms for three categories of hazard, all applied to a complex matrix of waxes, oils, emollients, and emulsifiers that each require specific sample preparation.
Analytical methods for cosmetics contaminants must deal with challenging matrices. Lipstick is a waxy lipid (castor oil, carnauba wax, candelilla wax mixture) that requires different extraction chemistry from an aqueous shampoo or a cream emulsion. Heavy metals and banned colourants may be present at very different concentrations in the same product, requiring different methods or separate extractions.
For heavy metals (lead, mercury, antimony, cadmium, arsenic, chromium, nickel) in cosmetics, the European Commission Reference Method is given in EU Regulation (EC) 333/2007 (for food) and adapted for cosmetics per the SCCS Notes of Guidance for Testing Cosmetic Ingredients. The procedure involves acid digestion of 0.5 to 1 g of cosmetic product with concentrated nitric acid and hydrogen peroxide in a closed microwave vessel, dilution, and analysis by ICP-MS. The relevant m/z values for common cosmetic heavy metals are: Pb at 206, 207, 208; Hg at 201, 202; Sb at 121, 123; As at 75; Cd at 111; Cr at 52; Ni at 60. For mercury specifically, cold-vapour atomic fluorescence spectrometry (CV-AFS) provides lower detection limits (sub-ng/g level) and is less susceptible to spectral interference than ICP-MS for low-level mercury in complex organic matrices. The US EPA Method 7473 (mercury analyser, thermal decomposition-amalgamation-AAS) is commonly used for mercury in solid cosmetic samples.
For lead in lip cosmetics specifically, the US FDA Elemental Analysis Manual 4.8 (EAM 4.8, updated 2011) uses ICP-MS with a LOQ of 0.1 mg/kg (0.1 ppm) in lipstick, aligned with the FDA 2016 guidance value of no more than 10 ppm lead in lip products. For survey purposes, HHXRF can screen cosmetics at higher concentrations, but the low-density, high-organic-content matrix of lipstick reduces HHXRF sensitivity compared to mineral-matrix samples; ICP-MS remains required for regulatory purposes.
For free formaldehyde quantification in cosmetics, the EU reference method uses the Nash reagent colorimetric procedure (Nash T., Biochem. J., 1953): formaldehyde reacts with ammonium acetate and acetylacetone to produce the yellow 3,5-diacetyl-1,4-dihydrolutidine chromophore (absorbance maximum 412 nm). The EU Commission Method (EN 14148:2003) is the standard for cosmetics. Sensitivity is approximately 1 mg/kg (1 ppm) free formaldehyde. For HPLC-UV, formaldehyde is derivatised with 2,4-dinitrophenylhydrazine (DNPH) to produce the stable formaldehyde-DNPH hydrazone, separated on C18 with acetonitrile-water gradient, and detected at UV 360 nm. The derivatisation-HPLC method is the reference in the ISO 14184-1:2011 (for textiles, but analytically equivalent to cosmetics applications). For GC-MS headspace analysis, the free formaldehyde is measured by static headspace injection; formaldehyde's low boiling point (MW 30, bp -19°C) ensures quantitative partitioning into the headspace from aqueous or semi-aqueous matrices.
For FTIR-ATR of formaldehyde-releasing preservatives in the intact cosmetic matrix, the C-N stretch of the FRP backbone and the characteristic N-CH2OH peaks can be identified by spectral library matching against FRP reference standards. This is a screening method rather than a quantitative one; it is useful for identifying which FRP class is present before the quantitative chemical methods are applied.
For banned colourants, HPLC-DAD with an acetonitrile-water gradient is the initial screen (visible-range DAD, 400-550 nm covers all major red, orange, and pink azo and xanthene dyes). Lipstick sample preparation: dissolve approximately 0.5 g in 5 mL acetonitrile by sonication (60°C, 10 minutes), filter (0.2 micron nylon), inject on C18 column. Identification by retention time and UV-Vis spectrum (DAD spectra should match the reference spectral library); confirmation by LC-MS/MS with dye-specific MRM transitions.
The same lead-containing kohl is legal to sell in some jurisdictions and grounds for a criminal prosecution in others. The patchwork of cosmetics regulation is one of the more striking examples of how different risk appetites produce different safety standards for the same global supply chain.
EU Regulation 1223/2009 (the Cosmetics Regulation) is the most comprehensive cosmetics safety framework globally. It applies to all cosmetic products placed on the EU market (including imports), irrespective of the manufacturer's location. Key provisions relevant to the chemistry discussed in this topic: Article 14 prohibits use of any colourant not listed in Annex IV; Article 15 requires that ingredients prohibited in Annex II (including lead, mercury, antimony, Sudan dyes, and all prohibited colourants) not be present in cosmetics at any level, except at trace concentrations technically unavoidable in good manufacturing practice. Annex III (restricted ingredients, which includes FRPs with their maximum concentrations) must be complied with for every batch.
Compliance monitoring is the responsibility of the "responsible person" (Article 4), who must maintain a Product Safety Report (PSR) under Article 10, including a cosmetic product safety assessment signed by a qualified cosmetic product safety assessor (CPSA). Market surveillance is conducted by national competent authorities (the UK MHRA, Germany's BfArM, France's ANSM, Italy's ISS and Ministero della Salute). RAPEX notifications (for dangerous non-food products including cosmetics) are publicly accessible on the European Commission's Safety Gate portal and serve the same coordination function as RASFF does for food. In the period 2015 to 2023, the RAPEX portal shows over 1,000 notifications for cosmetics containing banned colourants, heavy metals above trace, and prohibited preservatives.
In the United States, cosmetics were regulated under Sections 601-610 of the FD&C Act 1938, which prohibited the marketing of adulterated or misbranded cosmetics but imposed no pre-market approval requirement, no mandatory registration, no mandatory ingredient reporting, and no mandatory safety substantiation. The Modernization of Cosmetics Regulation Act 2022 (MoCRA) fundamentally changed this framework: it requires cosmetic-facility registration, product listing with FDA, adverse-event reporting, recall authority for FDA, and mandatory safety substantiation. MoCRA requirements began taking effect in 2024. For the specific hazards covered here, MoCRA's most immediate impact is the FRP labelling requirement and the requirement that fragrance allergens and formaldehyde-releasing ingredients be declared on the label by name.
In India, the Drugs and Cosmetics Act 1940 and the Cosmetics Rules 2020 (published in the Gazette, September 2020, replacing the old Schedule S framework) provide the regulatory basis. Schedule 1 of the Rules prohibits mercury, lead and lead compounds, arsenic, and a range of other heavy metals as cosmetic ingredients. Schedule 3 (restricted ingredients) lists permitted preservatives with maximum concentrations including formaldehyde at 0.2 per cent. The enforcement mechanism operates through the CDSCO and the State Drug Controllers, who license cosmetic manufacturers and can direct market recall. Imported cosmetics must be registered with the CDSCO (Form CT-11 under the Cosmetics Rules 2020); a certificate of analysis from an accredited Indian laboratory is required for registration. Products found non-compliant on market surveillance can be recalled under Section 22 of the D&C Act and the importer or responsible person prosecuted under Section 34A (penalty up to 3 years imprisonment and fine).
The enforcement gap between these frameworks is significant. In practice, the EU's responsible-person model creates a documented accountability chain for every product on the market. The US pre-MoCRA model had no mandatory registration and virtually no pre-market scrutiny of smaller brands. India's CDSCO focus on licensed large manufacturers leaves the informal import and local market segments less effectively monitored.
A pediatric physician in Birmingham, UK sees a 9-month-old Bangladeshi-British infant with blood-lead level of 48 micrograms per decilitre. The family reports no lead paint exposure, no water-lead source, and no occupational exposure. What cosmetic use history should be specifically asked about, and why?
| DMDM hydantoin | FRP: N-hydroxymethyl hydantoin; slow hydrolytic HCHO release | Same as free formaldehyde limit | FD&C Act voluntary; MoCRA 2022 review | Annex V Entry 43, max 0.2% as free HCHO | HPLC-DAD; LC-MS/MS |
| Lead (Pb) | Contaminant in inorganic pigments; intentional in kohl/galena | Prohibited as cosmetic ingredient (Schedule 1) | 1 ppm guidance for lip products (2016); kohl/galena DWPE via IA-66-01 | Prohibited (Annex II Entry 209); trace limit 10 mg/kg as contaminant | ICP-MS (USEPA 6020B); HHXRF field screen |
| Mercury (Hg) | Ammoniated Hg or HgI2 in skin-lightening; tyrosinase inhibitor | Prohibited as cosmetic ingredient (Schedule 1) | 1 ppm max (rinse-off); IA-66-01 for skin-lightening creams >1 ppm | Prohibited (Annex II Entry 221); 0.007% as thiomersal in eye preservatives only | ICP-MS; cold-vapour AAS; urine Hg biomonitoring |
| Antimony (Sb) | Contaminant in galena kohl; co-present with lead sulfide ore | No specific limit; general heavy-metal prohibition | No specific FDA limit; present in Import Alert IA-66-01 scope | Prohibited (Annex II Entry 35) | ICP-MS; SEM-EDX for galena particle identification |
| Rhodamine B | Banned azo/xanthene colourant; brilliant pink; SVHC candidate | Not permitted (no Annex IV equivalent listing) | Not permitted (FD&C Act; FDA D&C colour system excludes it) | Not listed in Annex IV (prohibited by default) | HPLC-DAD 540 nm; LC-MS/MS m/z 443.2→399.2 (+ESI) |